European Science Foundation

By Julia Karow
In an effort to unravel the genetics of monogenic forms of epilepsy, a consortium of researchers in Europe has embarked on the Genetics of Rare Epilepsy Syndromes project.

Calling for greater funding from governments, academia, nonprofits, and the private sector, the report said "recent years have witnessed an unprecedented gain of knowledge from" RNA research, yet Europe has "only has a few centers specifically funded to RNA research."

The European Science Foundation said it envisions the institute consisting of locally-funded, multidisciplinary centers with research groups in disciplines, such as biology, biochemistry, chemistry, genetics, bioinformatics, biophysics, structural analysis, microbiology, plant sciences, and clinical medicine.

The BBSRC and EPSRC have granted over $2 million to support synthetic biology projects involving UK/Europe collaborations.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.